SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026
Rhea-AI Summary
Sera Prognostics (Nasdaq: SERA) will report first quarter fiscal 2026 results on Wednesday, May 6, 2026, after market close and will host a conference call and live webcast at 5:00 p.m. ET. A press release with results and highlights will be distributed before the call.
Live audio and archived replay will be available on the company's Investors page at www.sera.com and the webcast will be archived for one year.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – SERA
On the day this news was published, SERA declined 0.23%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Before this call announcement, SERA was down 5.24%, while momentum peers were mixed: RCEL up 6.92% and LUCD down 2.34%, suggesting stock-specific factors rather than a uniform sector move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 04 | Earnings call scheduling | Neutral | -4.3% | Set date and time for Q4 and FY 2025 results call and webcast. |
| Oct 30 | Earnings call scheduling | Neutral | -2.1% | Announced Q3 2025 results date with related conference call logistics. |
| Jul 29 | Earnings call scheduling | Neutral | -1.0% | Outlined Q2 2025 results timing and access numbers for investors. |
| Apr 24 | Earnings call scheduling | Neutral | -2.0% | Provided Q1 2025 results date, call time, and dial-in information. |
| Mar 11 | Earnings call scheduling | Neutral | +1.9% | Announced Q4 and FY 2024 results release and related webcast details. |
Similar conference-call/earnings scheduling releases have led to modest average moves of -1.5%, with a slight negative bias.
Over the past year, Sera frequently issued conference-call and webcast notices around quarterly and annual results, typically after market close at 5:00 p.m. ET. These announcements, tagged as conferences/earnings, have produced small share-price moves, averaging -1.5% over 5 events. Today’s first-quarter fiscal 2026 call notice follows the same pattern of pre-announcing timing and access details, fitting into an established communications cadence around financial disclosures.
Historical Comparison
Past conferences/earnings call notices produced modest average moves of -1.5%, suggesting limited standalone impact from timing announcements.
Regular quarterly pattern of earnings call and webcast scheduling across fiscal 2024–2026.
Market Pulse Summary
This announcement schedules Sera’s Q1 FY 2026 results release for May 6, 2026 with a call at 5:00 p.m. ET, continuing a steady cadence of conference-call notices. Historically, such conferences/earnings tag releases have produced modest average moves of -1.5%. Investors may focus on previously reported cash levels, operating losses, and recent insider activity when evaluating upcoming results, with attention on how new disclosures compare to past filings.
AI-generated analysis. Not financial advice.
Conference Call Details:
US domestic callers: (800) 836-8184
International callers: (646) 357-8785
Webcast Registration Link: https://app.webinar.net/voeWlGmwyd6
Live audio of the webcast will be available online from the Investors page of the Company's website at www.sera.com. The webcast will be archived on the Investors page and will be available for one year.
About Sera Prognostics, Inc.
Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera's mission is to provide early, pivotal pregnancy information to improve the health of mothers and newborns, resulting in reductions in the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy. Sera's precision medicine PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera Prognostics is headquartered in
About Preterm Birth
Preterm birth is defined as any birth before 37 weeks' gestation and is the leading cause of illness and death in newborns. The 2025 March of Dimes Report Card shows that, for the fourth consecutive year, the United States earned a D+ grade for preterm birth, making the longest stretch of the lowest grade in Report Card history. Prematurity is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss, and can generate significant costs throughout the lives of affected children. The annual health care costs to manage short- and long-term complications of prematurity in
About the PreTRM® Test
The PreTRM® Test is the only broadly validated, commercially available blood-based biomarker test that provides an early, accurate and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies. The PreTRM® Test measures and analyzes proteins in the blood that are highly predictive of preterm birth. The PreTRM® Test permits physicians to identify, during the weeks 18 through 20 of pregnancy, which women are at increased risk for preterm birth and its complications, enabling more informed, personalized clinical decisions based on each woman's individual risk. The PreTRM® Test is ordered by a medical professional.
Sera, Sera Prognostics, the Sera Prognostics logo, The Pregnancy Company, and PreTRM are trademarks or registered trademarks of Sera Prognostics, Inc. in
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the date and time and content of the Company's quarterly earnings release and conference call; availability of the live audio of the conference call on the Company's website; and the Company's strategic directives under the caption "About Sera Prognostics, Inc." These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: net losses, cash generation, and the potential need to raise more capital; revenues from the PreTRM Test representing substantially all Company revenues to date; the need for broad scientific and market acceptance of the PreTRM Test; a concentrated number of material customers; our ability to introduce new products; potential competition; our proprietary biobank; critical suppliers; estimates of total addressable market opportunity and forecasts of market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests and market position; and other factors discussed under the heading "Risk Factors" contained in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our periodic and current reports filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
Investor Contact
Jennifer Zibuda, Head of Investor Relations
jzibuda@sera.com
+1 (801) 396-8043
View original content to download multimedia:https://www.prnewswire.com/news-releases/sera-prognostics-announces-conference-call-and-webcast-of-first-quarter-fiscal-year-2026-financial-results-on-may-6-2026-302749482.html
SOURCE Sera Prognostics, Inc.